K. Mais

发表

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

W. Ryder, J. Homer, N. Slevin, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cisplatin plus Capecitabine as First-Line Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Cancer: Experience Outside of a Trial Setting

N. Slevin, R. Swindell, A. McPartlin, 2013, Chemotherapy.

Quality of life measurement in the head and neck cancer radiotherapy clinic: is it feasible and worthwhile?

G. Humphris, N. Slevin, R. Swindell, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma

C. Rowbottom, G. Betts, N. Slevin, 2015, Acta oncologica.

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.

N. Slevin, A. Sykes, K. Mais, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.

A. Molassiotis, W. Ryder, N. Slevin, 2012, The British journal of oral & maxillofacial surgery.

P3.99. Dose related radiation-induced mucositis in oral andoropharyngeal cancer and its impact on quality of life

A. Molassiotis, N. Slevin, K. Mais, 2009 .

Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.

N. Slevin, J. Henk, R. Swindell, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review.

N. Slevin, A. Sykes, S. Mangar, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A systematic review of honey uses and its potential value within oncology care.

A. Molassiotis, N. Slevin, K. Mais, 2008, Journal of clinical nursing.

Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

W. Ryder, P. Julyan, T. Ward, 2011, The British journal of oral & maxillofacial surgery.

Radiologically inserted gastrostomies: their use in patients with cancer of the upper aerodigestive tract.

N. Slevin, K. Mais, J. Lawrance, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Imatinib with cisplatin in recurrent and/or metastatic salivary adenoidcystic carcinoma - response assessed by FDG-PET scanning

P. Julyan, T. Ward, J. Homer, 2004 .

Imatinib with cisplatin in recurrent and/or metastatic salivary adenoidcystic carcinoma - response assessed by FDG-PET scanning.

P. Julyan, T. Ward, J. Homer, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can synchronous chemotherapy be added to accelerated hypofractionated radiotherapy in patients with base of tongue cancer?

N. Slevin, A. Hartley, R. Swindell, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy

L. Kershaw, C. West, J. Homer, 2018, PloS one.

Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status

C. West, J. Homer, N. Slevin, 2018, Journal of Cancer Research and Clinical Oncology.